A Top 10 Pharma Company Doubles High‑Performing Site Count in a Priority Indication with Medidata AI Intelligent Trials

As a top 10 biopharmaceutical company embarked on clinical trials, it wanted to identify new Tier 1 sites and gain insight into the performance of its existing sites.

This in-depth case study explores how Medidata AI integrated cross-industry clinical trial data with the company’s data to more than double its list of high-performing sites.

While reading, you’ll learn more about:

• The challenges the company faced
• The benefits of Medidata AI data compared to publicly available data
• What advantages the company unlocked with Medidata AI

Use Medidata AI’s data to reimagine clinical trial site selection for your business.